Patents Assigned to RSPR Pharma AB
  • Publication number: 20170202839
    Abstract: There is provided a hemihydrate form of the sodium salt of pemirolast.
    Type: Application
    Filed: December 28, 2016
    Publication date: July 20, 2017
    Applicant: RSPR Pharma AB
    Inventors: Anett Perlberg, Martin Viertelhaus, Ulrika Rosenström, Karol Horvath
  • Patent number: 9492454
    Abstract: According to the invention there is provided pemirolast, or a pharmaceutically acceptable salt thereof, for use in the therapeutic treatment of asthma, such as an acute asthma attack. Suitable lower doses of pemirolast are least about 110 mg per day.
    Type: Grant
    Filed: February 4, 2016
    Date of Patent: November 15, 2016
    Assignee: RSPR Pharma AB
    Inventors: Johan Raud, Carl-Johan Dalsgaard, Jesper Säfholm
  • Publication number: 20160250217
    Abstract: There is provided a hemihydrate form of the sodium salt of pemirolast.
    Type: Application
    Filed: October 12, 2015
    Publication date: September 1, 2016
    Applicant: RSPR Pharma AB
    Inventors: Anett Perlberg, Martin Viertelhaus, Ulrika Rosenström, Karol Horvath
  • Patent number: 9415051
    Abstract: According to the invention there is provided a method for the treatment of airway hyperresponsiveness, which method comprises the administration of pemirolast, or a pharmaceutically acceptable salt thereof, to a patient in need of such treatment. Suitable lower doses of pemirolast are least about 110 mg per day.
    Type: Grant
    Filed: November 24, 2015
    Date of Patent: August 16, 2016
    Assignee: RSPR Pharma AB
    Inventors: Johan Raud, Carl-Johan Dalsgaard, Göran Tornling
  • Patent number: 9006431
    Abstract: There is provided a hemihydrate form of the sodium salt of pemirolast.
    Type: Grant
    Filed: May 12, 2014
    Date of Patent: April 14, 2015
    Assignee: RSPR Pharma AB
    Inventors: Anett Perlberg, Martin Viertelhaus, Ulrika Rosenström, Karol Horvath